Poland’s Top 500 Innovators visited The California Institute for Regenerative Medicine (CIRM)
On October 21, 2015, Poland’s Top 500 Innovators visited the California Institute for Regenerative Medicine (CIRM) in San Francisco, almost one year after CIRM and the Medical University of Warsaw (MUW), a Polish state university, signed a collaboration agreement on joint Polish-Californian initiatives to advance stem cell research. USPTC was instrumental in forging the agreement, having presented the idea to the leadership of CIRM and to the rector of MUW, prof. Marek Krawczyk, after a period of collaboration with the father of the legislative basis for CIRM, Mr. Robert Klein. As the agreement became effective on November 19, 2014, prof. Piotr Moncarz stated: “We are committed to supporting Polish researchers to work with California scientists and businesses to further boost Poland’s profile as an innovative and accelerating center for scientific research.” Following up his vision of collaboration, prof. Piotr Moncarz initiated a meeting between Poland’s 35 researchers and scientists and CIRM’s leadership represented by, among other things, Geoffrey Lomax, Dr. PH, Senior Officer of CIRM, and Jonathan Thomas, Ph.D., J.D., Chair, Governing Board of CIRM. A representative of the Top 500 Innovators, Wojciech Błogowski, MD, Ph.D., Department of Internal Medicine, University of Zielona Góra, Poland, outlined in his presentation the regenerative medicine activities in Poland, after which a substantive discussion on the prospective cooperation opportunities ensued among the meeting’s participants.